NASDAQ : APYX
Apyx Medical Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 2.6 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 109.52M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 109.52M |
| Enterprise Value | 121.54M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 42.12M |
| Shares Outstanding | 42.12M |
| Shares Change (YoY) | +10.48% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 13.56% |
| Owned by Institutions (%) | 41.64% |
| Float | 30.50M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.87 |
| Forward PS | 1.78 |
| PB Ratio | 10.27 |
| P/TBV Ratio | 10.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.68 |
| Quick Ratio | 4.41 |
| Debt / Equity | 3.57 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.63 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -90.69% |
| Return on Assets (ROA) | -3.71% |
| Return on Invested Capital (ROIC) | -4.55% |
| Return on Capital Employed (ROCE) | -6.84% |
| Weighted Average Cost of Capital (WACC) | 11.93% |
| Revenue Per Employee | $284,951 |
| Profits Per Employee | -$42,117 |
| Employee Count | 205 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 2.25 |
Taxes
| Measure | Value |
|---|
| Income Tax | 439,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.45 |
| 52-Week Price Change | -11.86% |
| 50-Day Moving Average | 2.77 |
| 200-Day Moving Average | 3.60 |
| Relative Strength Index (RSI) | 49.16 |
| Average Volume (20 Days) | 117,708 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 213,730 |
| Short Previous Month | 206,825 |
| Short % of Shares Out | 0.51% |
| Short % of Float | 0.70% |
| Short Ratio (days to cover) | 1.39 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 58.42M |
| Gross Profit | 37.09M |
| Operating Income | -3.54M |
| Pretax Income | -7.97M |
| Net Income | -8.63M |
| EBITDA | -2.76M |
| EBIT | -3.54M |
| Loss Per Share | -$0.20 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 27.62M |
| Total Debt | 39.63M |
| Net Cash | -12.01M |
| Net Cash Per Share | -$0.29 |
| Equity (Book Value) | 11.09M |
| Book Value Per Share | 0.25 |
| Working Capital | 43.80M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -10.13M |
| Capital Expenditures | -920,000 |
| Depreciation & Amortization | 783,000 |
| Net Borrowing | -20,000 |
| Free Cash Flow | -11.05M |
| FCF Per Share | -$0.26 |
Margins
| Measure | Value |
|---|
| Gross Margin | 63.50% |
| Operating Margin | -6.06% |
| Pretax Margin | -13.65% |
| Profit Margin | -14.78% |
| EBITDA Margin | -4.72% |
| EBIT Margin | -6.06% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -10.48% |
| Shareholder Yield | -10.48% |
| Earnings Yield | -7.79% |
| FCF Yield | -10.09% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $6.50 |
| Price Target Difference | 150.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 13.10% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jan 6, 1994 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.07 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |